- May 19, 2015
CVac Shows Clear Trend for Overall Survival Benefit in Second Remission Ovarian Cancer in Phase II Study
- May 15, 2015
Prima BioMed announces A$15 million investment from US Healthcare Investor Ridgeback.
- May 11, 2015
Prima BioMed announces Japanese Collaboration
PartneringFor information on partnering activities and for general licensing inquiries with Prima BioMed, please